Business Context and Reporting Period
This Form 8-K reports on the results of the 2018 Annual General Meeting (AGM) of uniQure N.V., held on June 13, 2018. The company is incorporated in The Netherlands and is classified as an emerging growth company. The filing details shareholder votes on financial accounts, board composition, equity plans, and auditor reappointment.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes and Voting Results
Shareholders voted on 13 agenda items. All proposals were passed. Key voting statistics include:
- Shareholder Participation: 28,217,619 ordinary shares were voted out of 36,987,788 eligible shares.
- Financial Accounts: The 2017 Dutch statutory annual accounts were adopted with 28,214,469 votes in favor.
- Board Discharge: The Board of Directors received discharge for 2017 management with 28,127,078 votes in favor.
- Board Elections:
- Mr. Astley-Sparke was re-elected as a non-executive director (23,700,362 votes in favor).
- Dr. Gut was elected as a non-executive director (28,204,846 votes in favor).
- Mr. Meek was elected as a non-executive director (28,204,546 votes in favor).
- Equity Plans:
- The 2014 Restated Plan was amended (19,531,698 votes in favor).
- The Employee Share Purchase Plan was approved (28,180,683 votes in favor).
- The Board was authorized to issue shares and limit preemptive rights under the 2014 Plan (21,525,682 votes in favor).
- The Board was reauthorized to issue shares and limit preemptive rights for an 18-month term (26,075,395 votes in favor).
- The Board was reauthorized to repurchase up to 10% of issued share capital (28,206,152 votes in favor).
- Auditor: PricewaterhouseCoopers Accountants N.V. (PwC) was reappointed as the independent registered public accounting firm for 2018 (27,897,511 votes in favor).
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. It notes the issuance of a press release regarding new board appointments, which is incorporated by reference as Exhibit 99.1.
Investor Verification Checklist
- Verify the full text of the press release regarding new board appointments (Exhibit 99.1) for details on Dr. Gut and Mr. Meek.
- Review the 2017 Dutch statutory annual accounts referenced in Agenda Item 5 for detailed financial performance.
- Confirm the specific terms of the amended 2014 Restated Plan and the new Employee Share Purchase Plan.
- Monitor future filings for the execution of the share repurchase authorization (up to 10% of share capital).